15,894 Shares in IMAX Corporation $IMAX Bought by Dakota Wealth Management

Dakota Wealth Management purchased a new stake in shares of IMAX Corporation (NYSE:IMAX) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 15,894 shares of the company’s stock, valued at approximately $587,000.

Other large investors have also made changes to their positions in the company. Aurora Investment Counsel raised its holdings in shares of IMAX by 0.4% during the 3rd quarter. Aurora Investment Counsel now owns 70,235 shares of the company’s stock valued at $2,300,000 after purchasing an additional 308 shares in the last quarter. Jones Financial Companies Lllp boosted its holdings in IMAX by 43.8% in the third quarter. Jones Financial Companies Lllp now owns 1,041 shares of the company’s stock worth $34,000 after purchasing an additional 317 shares in the last quarter. GAMMA Investing LLC increased its position in IMAX by 22.3% during the fourth quarter. GAMMA Investing LLC now owns 1,874 shares of the company’s stock worth $69,000 after buying an additional 342 shares during the last quarter. Arizona State Retirement System increased its position in IMAX by 2.8% during the third quarter. Arizona State Retirement System now owns 13,517 shares of the company’s stock worth $443,000 after buying an additional 364 shares during the last quarter. Finally, Legal & General Group Plc raised its holdings in IMAX by 1.5% during the second quarter. Legal & General Group Plc now owns 50,969 shares of the company’s stock valued at $1,425,000 after buying an additional 756 shares in the last quarter. Institutional investors own 93.51% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on IMAX. Wedbush reissued an “outperform” rating and issued a $46.00 price objective on shares of IMAX in a research note on Monday, February 23rd. Macquarie Infrastructure upped their target price on IMAX from $39.00 to $44.00 and gave the stock an “outperform” rating in a research report on Thursday, January 15th. Benchmark increased their price target on IMAX from $42.00 to $44.00 and gave the company a “buy” rating in a report on Thursday, February 26th. Barrington Research reissued an “outperform” rating and issued a $42.00 price target on shares of IMAX in a research report on Monday, January 26th. Finally, Wells Fargo & Company boosted their price objective on shares of IMAX from $40.00 to $47.00 and gave the stock an “overweight” rating in a research note on Thursday, December 18th. Ten research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, IMAX currently has an average rating of “Moderate Buy” and a consensus price target of $43.70.

IMAX Price Performance

Shares of IMAX stock opened at $37.61 on Tuesday. The company has a market cap of $2.03 billion, a PE ratio of 60.67, a price-to-earnings-growth ratio of 1.72 and a beta of 0.33. The firm has a fifty day moving average price of $37.53 and a two-hundred day moving average price of $35.67. IMAX Corporation has a fifty-two week low of $20.48 and a fifty-two week high of $43.16.

IMAX (NYSE:IMAX) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.15. IMAX had a net margin of 8.50% and a return on equity of 13.53%. The company had revenue of $125.21 million for the quarter, compared to the consensus estimate of $120.30 million. During the same quarter in the previous year, the firm posted $0.27 EPS. The business’s revenue was up 35.1% compared to the same quarter last year. Analysts expect that IMAX Corporation will post 0.91 earnings per share for the current fiscal year.

IMAX News Roundup

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: Box‑office lift from Project Hail Mary is material for IMAX; the film has been a major contributor to IMAX ticket revenue and premium format sales, supporting near‑term theatrical demand and exhibitor pricing power. Read More.
• Positive Sentiment: Project Hail Mary outperformed other recent releases on IMAX screens and the company is keeping it as a recurring feature, which should extend IMAX’s revenue tail from the title through repeat engagements and higher per‑screen grosses. Read More.
• Positive Sentiment: Recent fundamental backdrop: IMAX reported a fiscal quarter beat (EPS and revenue ahead, revenue +35% YoY) in late February, showing improving margins and box‑office leverage — a reminder that recent operating momentum underpins valuation. (Company quarterly release)
• Neutral Sentiment: Company press release states senior executives will run the business per the operating plan during the CEO’s temporary absence, signaling continuity and lowering near‑term operational risk. Read More.
• Negative Sentiment: CEO Richard Gelfond is on a temporary medical leave to receive treatment for pneumonia. Leadership absences can create short‑term governance and execution concerns; however, the company says he is receiving care and progressing in recovery. Investors may monitor updates on duration and any interim leadership plans. Read More.

Insider Activity

In other IMAX news, insider Kevin Douglas sold 330,200 shares of the company’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $37.82, for a total value of $12,488,164.00. Following the completion of the transaction, the insider owned 3,657,450 shares of the company’s stock, valued at $138,324,759. This represents a 8.28% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Richard L. Gelfond sold 121,220 shares of the firm’s stock in a transaction that occurred on Tuesday, March 10th. The stock was sold at an average price of $40.10, for a total value of $4,860,922.00. Following the completion of the sale, the chief executive officer owned 765,002 shares of the company’s stock, valued at $30,676,580.20. This represents a 13.68% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 689,220 shares of company stock worth $26,342,682 over the last 90 days. Corporate insiders own 24.08% of the company’s stock.

About IMAX

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.